News
MU Announces Investment in Radiopharmacology Core
MU announces funding for a new Radiopharmacology Core, a partnership between MURR®, the School of Medicine, and the Colleges of Veterinary Medicine and Arts & Science.
Archaeometry Lab at MURR® receives funding from National Science Foundation
MURR’s Archaeometry Laboratory has received a new grant from the NSF.
MURR® is featured on SNMMI-TV at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting
A video featuring MURR® was broadcast at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
MU reactor plays important role in nuclear medicine advancements
A featured article about MURR® in the Columbia Missourian.
Revelations about radioactive zirconium forge a new path in research about the universe
Findings from MU study could hint at a wealth of neglected potential in radioactive chemical isotopes.
For First Time in 30 years, Critical Medical Radioisotope Has Domestic Supplier
MURR® recently shipped its first batch of I-131, making it the only supplier of I‑131 in the United States and the first U.S. supplier since the 1980s.
MURR® Receives New 20-year Operating License from the U.S. Nuclear Regulatory Commission
MURR® has received a new 20-year operating license from the U.S. Nuclear Regulatory Commission (NRC).
MURR Working to Stabilize Supply of Cancer Drugs
Due to unexpected interruptions at international reactors, MURR® will change maintenance schedule to maintain drug supply for the nation